PREVIEW ASH 2026 — New Orleans, Dec 12–15: the abstracts hematologists are watching, top voices and trial buzz See the ASH 2026 preview →
KOL Pulse Insights Blog

Oncology KOL Intelligence, decoded.

Key opinion leader trends, clinical-trial commentary, conference recaps, and AI-native intelligence on the physicians shaping oncology practice — straight from the social conversation.

1Articles
WeeklyNew insights
500+Verified oncologists tracked
0 articles · All topics
ESMO 2026: Top GU Cancer Trials and KOL Voices
Oct 25, 2026, 7:42:21 AM Brian Shields

ESMO 2026: Top GU Cancer Trials and KOL Voices

ESMO 2026 Madrid GU cancers, October 23–26: VOLGA, KEYNOTE-866, DASL-HiCaP, LITESPARK-012 and TALAPRO-3, FDA approved October 26, with verbatim physician reacti…

kol reactionsesmo 2026bladder cancer

Track the KOLs shaping oncology

KOL Pulse turns the oncology social conversation into AI-native intelligence. See it in action.

Book a Demo Back to Homepage